Jean Coutu Group PJC Inc (TSE:PJC.A)‘s stock had its “neutral” rating restated by stock analysts at Dundee Securities in a report issued on Thursday. They currently have a C$20.00 price target on the stock.

Several other brokerages have also weighed in on PJC.A. TD Securities reissued a “reduce” rating and set a C$17.50 price objective on shares of Jean Coutu Group PJC in a report on Monday, July 18th. Royal Bank Of Canada decreased their price objective on Jean Coutu Group PJC from C$20.00 to C$19.00 and set a “sector perform” rating on the stock in a report on Wednesday, July 6th. CIBC reissued a “sector perform” rating and set a C$19.00 price objective on shares of Jean Coutu Group PJC in a report on Wednesday, July 6th. Finally, Scotiabank reissued a “sector perform” rating and set a C$19.00 price objective on shares of Jean Coutu Group PJC in a report on Tuesday, July 5th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Jean Coutu Group PJC has an average rating of “Hold” and an average price target of C$19.19.

Jean Coutu Group PJC Company Profile

The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.

Receive News & Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related companies with MarketBeat.com's FREE daily email newsletter.